Search results for "Patient-reported"

showing 10 items of 49 documents

Assessment of Construct Validity of the Oswestry Disability Index and the Scoliosis Research Society–30 Questionnaire (SRS-30) in Patients With Degen…

2019

Observational cohort study.To measure and compare the structural validity of the Oswestry Disability Index (ODI) and the Scoliosis Research Society-30 (SRS-30) questionnaire in an adult population with prolonged degenerative thoracolumbar disease.The ODI and the SRS-30 are commonly used patient-reported outcome instruments to assess back-specific disability and symptoms related to scoliosis. Still, these instruments have not been validated for degenerative spinal disease with different stages of deformity.Altogether, 637 consecutive adult patients with degenerative spinal pathologies were included. The patients completed the ODI (version 2.0), the 23 preoperative items of the SRS-30, a gene…

AdultMalemedicine.medical_specialtyPsychometricsVisual Analog ScaleVisual analogue scaleScoliosisSpinal diseaseDisability Evaluation03 medical and health sciences0302 clinical medicineDegenerative diseaseSurveys and QuestionnairesOsteoarthritisBack painHumansMedicineOrthopedics and Sports MedicinePatient Reported Outcome MeasuresProspective StudiesAgedPsychiatric Status Rating Scales030222 orthopedicsbusiness.industryConstruct validityMiddle Agedmedicine.disease3. Good healthOswestry Disability IndexRadiographyScoliosisBack PainQuality of LifePhysical therapyFemaleSpinal DiseasesPatient-reported outcomemedicine.symptombusiness030217 neurology & neurosurgerySpine Deformity
researchProduct

The Urticaria Activity Score-Validity, Reliability, and Responsiveness.

2018

Background Chronic spontaneous urticaria is characterized by fluctuating symptoms. Its activity is assessed with the urticaria activity score (UAS). Two versions of the urticaria activity score used for 7 consecutive days (UAS7) are available: (1) The guideline-recommended UAS7, with once-daily documentation, and (2) the UAS7TD, with twice-daily documentation. Objective To better characterize both UAS7 versions with regard to their validity, reliability, sensitivity to change, minimal important difference (MID), and smallest detectable change (SDC). Methods One hundred thirty adult patients with chronic spontaneous urticaria completed both UAS7 versions, the Patients Global Assessment (PatG…

AdultMalemedicine.medical_specialtyUrticariaIntraclass correlationOmalizumabOmalizumabSeverity of Illness IndexDisease activity030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineQuality of lifeimmune system diseasesInternal medicineAnti-Allergic AgentsImmunology and AllergyMedicineHumansskin and connective tissue diseasesReceiver operating characteristicbusiness.industryReproducibility of ResultsDermatology Life Quality IndexMiddle AgedStandard error030228 respiratory systemChronic DiseasePhysical therapyPatient-reported outcomeFemalebusinessmedicine.drugThe journal of allergy and clinical immunology. In practice
researchProduct

Design and validation of a patient-reported outcome measure scale in acute pancreatitis: the PAN-PROMISE study

2021

ObjectiveThis study aimed to develop and validate a patient-reported outcome measure (PROM) in acute pancreatitis (AP) as an endpoint centred on the patient.DesignA PROM instrument (PAtieNt-rePoRted OutcoMe scale in acute pancreatItis, an international proSpEctive cohort study, PAN-PROMISE scale) was designed based on the opinion of patients, professionals and an expert panel. The scale was validated in an international multicentre prospective cohort study, describing the severity of AP and quality of life at 15 days after discharge as the main variables for validation. The COSMIN (COnsensus-based Standards for the selection of health status Measurement INstruments) methodology was applied.…

AdultMalemedicine.medical_specialtyacute pancreatitisOrdinal ScalePromCohort Studies03 medical and health sciences0302 clinical medicinePredictive Value of TestsCriterion validitymedicineHumansPatient Reported Outcome Measures030212 general & internal medicineProspective cohort studyReliability (statistics)AgedFace validityHospital Prof. Dr. Fernando Fonseca E.P.E.business.industryGastroenterologyReproducibility of ResultsPAN-PROMISE study.Middle AgedHospitalizationClinical trialClinical trialPancreatitisQuality of LifePhysical therapyFemale030211 gastroenterology & hepatologyPatient-reported outcomeSymptom AssessmentbusinessGut
researchProduct

Burden of disease in patients with Morquio A syndrome: results from an international patient-reported outcomes survey

2013

WOS: 000335253700001

AdultQuality of lifemedicine.medical_specialtyActivities of daily livingInternationalityAdolescentDiseaseShort staturechemistry.chemical_compoundWheelchairQuality of lifeElosulfase alfaMedicineHumansGenetics(clinical)Pharmacology (medical)ChildGenetics (clinical)FatigueMobilityMedicine(all)Pain measurementPatient-reported outcomesbusiness.industryData CollectionResearchMucopolysaccharidosis IVGeneral MedicineGaithumanitiesEQ-5D-5LchemistryWheelchairsJoint painPhysical therapymedicine.symptombusinessMorquio A syndromeOrphanet Journal of Rare Diseases
researchProduct

Electronic Patient-Reported Outcome Measures Evaluating Cancer Symptoms: A Systematic Review.

2021

Abstract Objectives This systematic review aims to evaluate the psychometric properties and the methodologic quality of studies describing smartphone-, tablet- or computer-based questionnaires for Patient-Reported Outcome Measures (PROM) evaluating symptoms in oncology and hematology patients. Data Sources A literature search was conducted in PubMed, Scopus, Cochrane, Cinahl, Cuiden, Lilacs, and PsycINFO. Criteria for inclusion were (i) primary studies evaluating scales for symptoms assessment, (ii) developed in adult population (>18 years) with an oncology or hematology malignancy diagnosis, (iii) validations tested via phone or computer, and (iv) describing at least one psychometric prope…

Adultmedicine.medical_specialtyPsychometricsPsychometricsOncology (nursing)business.industryConstruct validityReproducibility of ResultsCommon Terminology Criteria for Adverse EventsPsycINFOCINAHLElectronic patient-reported outcomeChecklist03 medical and health sciences0302 clinical medicine030220 oncology & carcinogenesisNeoplasmsmedicineContent validityHumansMedical physics030212 general & internal medicinePatient Reported Outcome MeasuresElectronicsbusinessSeminars in oncology nursing
researchProduct

Update on the ESCEO recommendation for the conduct of clinical trials for drugs aiming at the treatment of sarcopenia in older adults

2020

Abstract Background In 2016, an expert working group was convened under the auspices of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and formulated consensus recommendations for the conduct of clinical trials for drugs to prevent or treat sarcopenia. Aims The objective of the current paper is to provide a 2020 update of the previous recommendations in accordance with the evidence that has become available since our original recommendations. Methods This paper is based on literature reviews performed by members of the ESCEO working group and followed up with face to face meetings organized for the whole group to make amendments and discuss…

AgingSarcopeniaGeriatrics & GerontologyStandardizationDiseaseReviewRecommendationsFace-to-face0302 clinical medicineQUALITY-OF-LIFEGAIT SPEEDClinical trial; Drug registration; Guidelines; Recommendations; Sarcopenia; Treatment; Aged; Humans; Muscle Strength; Osteoarthritis; Osteoporosis; Pharmaceutical Preparations; Sarcopenia030212 general & internal medicineMUSCLE MASSDIETARY-PROTEINClinical trialPhysical limitationsPharmaceutical Preparations/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_beingPatient-reported outcomeGRIP STRENGTHLife Sciences & Biomedicinemedicine.medical_specialtyNUTRITIONAL-STATUSBODY-COMPOSITION030209 endocrinology & metabolismGuidelines03 medical and health sciencesClinical trial · Sarcopenia · Guidelines · Recommendations · Drug registration · TreatmentSDG 3 - Good Health and Well-beingOsteoarthritismedicineHumansMuscle StrengthDrug registrationAgedScience & Technologybusiness.industryWORKING GROUPmedicine.diseaseComorbidityClinical trialTreatmentSarcopeniaPATIENT-REPORTED OUTCOMESPhysical therapyOsteoporosisGeriatrics and GerontologyPHYSICAL PERFORMANCEbusinessAging Clinical and Experimental Research
researchProduct

Real-life assessment of chronic rhinosinusitis patients using mobile technology: the mySinusitisCoach project by EUFOREA

2020

Abstract Background Chronic rhinosinusitis (CRS) is a chronic inflammatory disease associated with a substantial personal and socioeconomic burden. Monitoring of patient‐reported outcomes by mobile technology offers the possibility to better understand real‐life burden of CRS. Methods This study reports on the cross‐sectional evaluation of data of 626 users of mySinusitisCoach (mSC), a mobile application for CRS patients. Patient characteristics of mSC users were analysed as well as the level of disease control based on VAS global rhinosinusitis symptom score and adapted EPOS criteria. Results The mSC cohort represents a heterogeneous group of CRS patients with a diverse pattern of major sy…

Aplicacions mòbilsSYMPTOMSSinusititsvisual analogue scale0302 clinical medicineQuality of lifeMedicine and Health SciencesImmunology and AllergyNasal polyps030223 otorhinolaryngologyRhinitisnasal polypreal‐world evidenceASSOCIATION3. Good healthPREVALENCEALLERGIC RHINITISpatient-reported outcome measureCohortOriginal Articlepatient‐reported outcome measureENDOSCOPIC SINUS SURGERYmedicine.medical_specialtyVisual analogue scaleImmunologyMobile health technology03 medical and health sciencesNasal PolypsInternal medicinemedicineotorhinolaryngologic diseasesHumansNASALSinusitisreal-world evidenceDisease burdenMobile health technology; nasal polyp; patient-reported outcome measure; real-world evidence; visual analogue scaleTelecommunication in medicineAsthmabusiness.industryRhinitis Sinusitis and Upper Airway DiseaseFunctional endoscopic sinus surgerymedicine.diseasePrecision medicineSEVERITYCross-Sectional Studies030228 respiratory system3121 General medicine internal medicine and other clinical medicineChronic DiseaseMobile appsQuality of LifeASTHMAHuman medicineORIGINAL ARTICLESVISUAL ANALOG SCALEbusinessTelecomunicació en medicina
researchProduct

Physicians' Perceptions of Clinical Utility of a Digital Health Tool for Electronic Patient-Reported Outcome Monitoring in Real-Life Hematology Pract…

2022

Digital health tools are increasingly being used in cancer care and may include electronic patient-reported outcome (ePRO) monitoring systems. We examined physicians’ perceptions of usability and clinical utility of a digital health tool (GIMEMA-ALLIANCE platform) for ePRO monitoring in the real-life practice of patients with hematologic malignancies. This tool allows for the collection and assessment of ePROs with real-time graphical presentation of results to medical staff. Based on a predefined algorithm, automated alerts are sent to medical staff. Participating hematologists completed an online survey on their experience with the platform. Of the 201 patients invited to participate betw…

Cancer Researchhematologydigital healthleukemialymphomaSettore MED/15patient-reported outcomes (PROs)digital health hematology leukemia lymphoma multiple myeloma patient-reported outcomes (PROs) quality of life symptomsmultiple myelomaOncologyquality of lifesymptomsdigital health; hematology; leukemia; lymphoma; multiple myeloma; patient-reported outcomes (PROs); quality of life; symptoms
researchProduct

2020

The disease and treatment of patients with head and neck cancer can lead to multiple late and long-term sequelae. Especially pain, psychosocial problems, and voice issues can have a high impact on patients’ health-related quality of life. The aim was to show the feasibility of implementing an electronic Patient-Reported Outcome Measure (PROM) in patients with head and neck cancer (HNC). Driven by our department’s intention to assess Patient-Reported Outcomes (PRO) based on the International Classification of Functioning during tumor aftercare, the program “OncoFunction” has been implemented and continuously refined in everyday practice. The new version of “OncoFunction” was evaluated by 20 …

Cancer Researchmedicine.medical_specialtybusiness.industryHead and neck cancerDiseasePrommedicine.disease03 medical and health sciences0302 clinical medicineOncologyQuality of lifeInternational Classification of Functioning Disability and Health030220 oncology & carcinogenesismedicinePhysical therapyIn patientPatient-reported outcome030223 otorhinolaryngologybusinessPsychosocialFrontiers in Oncology
researchProduct

The impact of preoperative neurological symptom severity on postoperative outcomes in cervical spondylotic myelopathy

2021

Study Design: The study design is a retrospective cohort study.Objective: To compare patient-reported outcomes between patients with mild versus moderate-to-severe myelopathy following surgery for cervical spondylotic myelopathy (CSM).Summary of Background Data: Recent studies have demonstrated that decompression for CSM leads to improved quality of life when measured by patient-reported outcomes. However, it is unknown if preoperative myelopathy classification is predictive of superior postoperative improvements.Materials and Methods: A retrospective review of patients treated surgically for CSM at a single institution from 2014 to 2015 was performed. Preoperative myelopathy severity was c…

Cervical spondylosimyelopathySurgeryNeurology (clinical)modified Japanese Orthopaedic Associationpatient-reported outcome
researchProduct